Sensitivity analysis after including all patient-years with no history of asthma related healthcare use. (DOCX 18 kb
AEs reported by âĽ3 patients in the Japan+Korea cohort of any relevant treatment arm and the corres...
Table S1. Baseline characteristics. Table S2. Baseline values of measurements of small airways dysfu...
Table S1. Unweighted regression results of smoking within 5Â min of waking on asthma outcomes. (DOCX...
Table S2. Â Odd ratios of association between comorbid conditions on ICS to total medications <â50...
Flowchart of the study population. Detailed information on characteristics and co-medication of case...
Scoring for severity of asthma modified by Eisnerâs method. Table S2: Pearson correlation coeffici...
Profile of the two additional Phase IIb studies included in only the safety analyses. (DOCX 25.6 KB
Additional results for patient demographics and baseline characteristics, exacerbation rates, exacer...
This file contains a detailed description of the methods along with Figure E1 and Tables E1 through ...
Algorithm used to calculate current and past use in the cohort analysis. Schematic description of th...
Criteria for exclusion of children with severe asthma and non-severe persistent asthma. (PDF 11Â kb
Criteria for inclusion of children with severe asthma and non-severe persistent asthma. (PDF 25Â kb
Profile of the three Phase III studies included in both the efficacy and safety analyses. (DOCX 47.4...
âStudy questionnaires used in the CORE studyâ contains description of the patient-reported quest...
Summary of the most common adverse events (âĽ5%) in the Asian and non-Asian populations. (DOCX 24 k...
AEs reported by âĽ3 patients in the Japan+Korea cohort of any relevant treatment arm and the corres...
Table S1. Baseline characteristics. Table S2. Baseline values of measurements of small airways dysfu...
Table S1. Unweighted regression results of smoking within 5Â min of waking on asthma outcomes. (DOCX...
Table S2. Â Odd ratios of association between comorbid conditions on ICS to total medications <â50...
Flowchart of the study population. Detailed information on characteristics and co-medication of case...
Scoring for severity of asthma modified by Eisnerâs method. Table S2: Pearson correlation coeffici...
Profile of the two additional Phase IIb studies included in only the safety analyses. (DOCX 25.6 KB
Additional results for patient demographics and baseline characteristics, exacerbation rates, exacer...
This file contains a detailed description of the methods along with Figure E1 and Tables E1 through ...
Algorithm used to calculate current and past use in the cohort analysis. Schematic description of th...
Criteria for exclusion of children with severe asthma and non-severe persistent asthma. (PDF 11Â kb
Criteria for inclusion of children with severe asthma and non-severe persistent asthma. (PDF 25Â kb
Profile of the three Phase III studies included in both the efficacy and safety analyses. (DOCX 47.4...
âStudy questionnaires used in the CORE studyâ contains description of the patient-reported quest...
Summary of the most common adverse events (âĽ5%) in the Asian and non-Asian populations. (DOCX 24 k...
AEs reported by âĽ3 patients in the Japan+Korea cohort of any relevant treatment arm and the corres...
Table S1. Baseline characteristics. Table S2. Baseline values of measurements of small airways dysfu...
Table S1. Unweighted regression results of smoking within 5Â min of waking on asthma outcomes. (DOCX...
DOI
Add to ORKG